Ten-year-old XNK Therapeutics experiences rapid growing with own GMP facility
XNK Therapeutics has expanded significantly in the past year and now has access to its own GMP-standard production lab.
“We need to have significantly larger capacity to conduct the larger Phase II studies we’re planning. That capacity isn’t available in Sweden, so we’ve built up our own lab in Flemingsberg,” says Johan Liwing, CEO of XNK Therapeutics.
XNK has grown rapidly in recent years and today the company employs almost 30 people in Novum in Flemingsberg. The new GMP facility, with 350sqm of research laboratory space, gives the company better control over its development chain.
Unique technology
XNK Therapeutics was founded in 2012 and is a pioneer in cell therapy. With a unique platform technology, the company focuses primarily on new forms of cancer treatment. The platform enables new cell-based treatments with autologous NK cells.
A clinical investigator-sponsored Phase II study is already being conducted at Karolinska University Hospital, where XNK’s drug candidate is being combined with Sanofi’s anti-CD38 antibody Sarclisa, Isatuximab, for treatment of the severe cancer form multiple myeloma.
“We’re extremely proud of this smaller Phase II study and now we need to increase production capacity. Myeloma is our main focus area, but when we’ve reached the right capacity, there’ll be one or two more [candidates]. It’s important to create a good width outside the blood cancer area,” says Liwing.
XNK Therapeutics is currently conducting a number of projects, including a “proof of concept” study together with the University of Texas MD Anderson Cancer Center in the field of acute myeloid leukemia (AML).
At the beginning of the year, the company raised approximately SEK 130 million in new capital to drive growth.
“It feels great and above all the fact that it’s not only about capital but also provides the addition of competence and production knowledge through NorthX Biologics. We complement each other in a way that enables good synergies,” says Liwing.
“Flemingsberg is the ideal place for us with immediate proximity to everything we need. It’s also home to research in a world-leading research hub and a proximity to a clinic that really knows NK cells.”
Read more about xnktherapeutics.com.
Limitless Potential: Winner of the Flemingsberg Science Award 2025
Young people in disadvantaged areas often face mental health challenges and a lack of support, which can lead to isolation and destructive choices. Limitless Potential, winner of the Flemingsberg Science Award IDEA 2025, has created a safe space where creativity and social entrepreneurship come together to support youth.
Alfa Laval strengthens Flemingsberg – establishes itself in a growing city of the future
In May 2025, Alfa Laval moved into its new office and innovation center, spanning approximately 20,000 square meters, together with around 700 employees. At the same time, the restaurant K-märkt opened, further expanding the range of services available in Flemingsberg. The Royal Swedish Opera and Dramaten, Alfa Laval, Restaurant Billmans, and K-märkt all represent important pieces of the puzzle in the development of Flemingsberg.
En nationell resurs för morgondagens behandlingar – nu är Karolinska ATMP Centrum invigt
Med ett tydligt budskap om framtidstro och ett kraftfullt samarbete invigdes Karolinska ATMP Centrum i Flemingsberg i slutet av augusti. Centret är ett samarbete mellan Karolinska Institutet och Karolinska Universitetssjukhuset, och kommer fungera som en nationell resurs för tillverkning av avancerade terapier (ATMP), där forskning, kliniska prövningar och behandlingar smidigt samverkar för att leverera banbrytande terapier till patienter.
She’s Building Bridges Between People and Place – Meet Karin, the Placemaker Behind the Future of Flemingsberg
Karin Lekberg is paving the way for the Flemingsberg of the future, a place where knowledge and creativity meet. She envisions a vibrant area full of culture, evening and nightlife, and a natural meeting place for both students and creators. But when the goal feels far away, it’s about starting where you are, creating life and activity here and now, and above all, building on the stories that already exist, allowing the place to grow into its future.
Hon bygger broar mellan människor och plats – möt Karin, platsmäklaren bakom framtidens Flemingsberg
Karin Lekberg krattar vägen för framtidens Flemingsberg, platsen där kunskap och kreativitet möts. Hon vill skapa ett levande område med kultur, kvälls- och nattliv, och en naturlig plats för både studenter och kreatörer. Men när målet känns långt bort handlar det om att börja där man står, att skapa liv och aktiviteter här och nu, och inte minst bygga vidare på de berättelser som redan finns och låta platsen växa in i sin framtid.
